Replies to post #155917 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

I’m content waiting for this to drop back down to the mid $2s before I re-enter. Time is in my side.

Do whatever you want but IMO, you have completely misjudged the dynamics of this situation.

[LakeshoreLeo1953]

Better scrutiny of the "PR" Tuesday did give
rise to author, forum, and specifics questions. But.....

Pre AAIC and perhaps 20 days to return home,
I'll let my Tuesday re entry ride. $3.43 (off which it just bounced)
until I lose the edge from the two Summer trades.

Penny's "advert" post probably the reason I don't
try to take the trade and join you at a lower pps.

Execution will be critical. The Science will be what it is.
Personal hope is that second derivative analysis is not
necessary to make a positive spin on data.

If, IF, IF, IF.....Enrollment accomplished near Fall. Dosing
by EOY. Earliest data Valentine's Day 2019 (LOL).

Last oil change and rear tire appt for the trip. Too hot for golf.

[poguemahone]

While I applaud DM for getting approval to start a thorough, comprehensive, and statitically meaningful drug trial, this is perhaps what has taken some of the air out the balloon. Even though we are in the early stages of CNS precision medicine, the statisticians still require a certain number of trial participants in order to allow for it to be powerful. So while we may have precision medicine, the testing needed to prove it effective will still prove ti be more expensive than DM hoped. A trial this size, scope, and duration will require more resources than originally thought. AND, we still have 2 more trials (Rett & PD) that have not been announced. We will either need to dilute, partner, or scale back some of the other trials. I think this is why the SP is responding the way it has today—EUPHORIA has given way to the economics of running these trials.